The Possibility to Use Medications Purchased at the Expense of a Patient in Intensive Care Units of Healthcare Institutions
The purpose of the study: to identify a legally justified possibility for a patient (patient's relatives) to purchase a drug product (DP), which has not been purchased by a healthcare institution but is recommended by the doctor in charge «by lifesaving indication» as the most effective one.Mat...
Saved in:
Main Authors: | O. Yu. Aleksandrova, A. A. Sokolov |
---|---|
Format: | Article |
Language: | English |
Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2017-09-01
|
Series: | Общая реаниматология |
Subjects: | |
Online Access: | https://www.reanimatology.com/rmt/article/view/1605 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artificial Intelligence (AI) and Drug-Induced and Idiosyncratic Cytopenia: The Role of AI in Prevention, Prediction, and Patient Participation
by: Emmanuel Andrès, et al.
Published: (2025-04-01) -
Ceftriaxone-Induced Pancytopenia: A Case Report
by: Edin Karisik, et al.
Published: (2025-06-01) -
The dance of the medical consultation
by: Chris Ellis
Published: (2014-09-01) -
A Real-World Experience With Resmetirom: Tolerability and Access
by: Sameera Shuaibi, et al.
Published: (2025-01-01) -
Trends in Antihypertensive Drug Use and Irrational Prescriptions Among Elderly Patients in China (2016–2023): A Nationwide Multi-Center Cross-Sectional Survey Study
by: Hong D, et al.
Published: (2025-07-01)